Woodley Equipment Company Exhibiting at Partnerships in Clinical Trials Europe 2016
pharmafile | November 1, 2016 | News story | | PCT, clinical trials
Woodley Equipment Company is exhibiting at Partnerships in Clinical Trials Europe, which is taking place on 16-17 November 2016 at the Reed Messe Wien Congress Center, Vienna.
Woodley Equipment Company is a leading specialist provider of equipment rental and purchase solutions. Supporting the largest and smallest Clinical Trials around the world with the lowest cost equipment solutions.
Come and see us on Stand 323 and find out how our complete equipment service can bring simplicity to your next Clinical Study.
Our close long standing relationships with customers and suppliers, and 27 years experience in the Industry has given us a unique insight into the challenges of conducting Clinical Trials around the world. Our experienced staff and custom-built IT systems ensure the ongoing success of all Clinical Trials in our care.
Put simply, we won’t let you down…
• Our services include: sourcing, supplying and maintaining equipment, supplying consumable items and kit supplies
• We adopt a flexible and timely responsive approach to your requests
• Partnering with our customers to provide a ‘one stop’ equipment solution
• Experienced staff working to Industry standards
• Equipment rental and purchase options available or a tailored combination of both
• Equipment stock held at our warehouses in the United Kingdom and United States.
• Complete peace of mind for all of your Clinical Trials in our care.
If you would like to arrange to meet with a representative of Woodley Equipment at Partnerships in Clinical Trials Europe in Vienna, or find out more information about any of our products or services, please contact us at enquiries@woodleyequipment.com. Alternatively please call us on +44 (0)8456 777 001 to speak to one of our Account Managers.
Related Content
Gilead and Merck share data from phase 2 trial of HIV treatment
Gilead Sciences and Merck (known as MSD outside of the US and Canada) have announced …
FDA clears Aruna Bio’s IND for AB126 to enter clinical trials
Aruna Bio has announced that the US Food and Drug Administration (FDA) has cleared its …
Genentech shares phase 3 results for ALK-positive early-stage lung cancer treatment
Roche’s Genentech has announced that the phase 3 ALINA trial assessing Alecensa, compared with platinum-based …
